Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ruf

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Molecular Therapy Oncolytics|April 28, 2016
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?Benjamin Ruf, Ulrich M Lauer
Cellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Patterns (New York, N.Y.)|July 15, 2026
SHIELD: A weakly supervised graph attention neural network for decoding disease-relevant cell-cell interactionsVivek Sehra, Benjamin Ruf, Gabriel Duval, et al.
Journal of Telemedicine and Telecare|June 7, 2019
Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural settingBenjamin Ruf, Phillip Jenkinson, David Armour, et al.
Trends in Immunology|June 15, 2024
Innate-like T cells in liver diseaseAlbert Ying-Po Yang, Kilian Wistuba-Hamprecht, Tim F Greten, et al.
Journal of Gastrointestinal Cancer|May 2, 2022
Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic SurveillanceBenjamin Ruf, Cristiana Roggia, Christopher Schroeder, et al.
Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Molecular Therapy Oncolytics|April 28, 2016
Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinomaBenjamin Ruf, Susanne Berchtold, Sascha Venturelli, et al.
Cancers|May 13, 2023
Anti-Cancer Activity of Verteporfin in CholangiocarcinomaJihye L Golino, Xin Wang, Jing Bian, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Therapy Oncolytics|April 28, 2016
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?Benjamin Ruf, Ulrich M Lauer
Cellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Patterns (New York, N.Y.)|July 15, 2026
SHIELD: A weakly supervised graph attention neural network for decoding disease-relevant cell-cell interactionsVivek Sehra, Benjamin Ruf, Gabriel Duval, et al.
Journal of Telemedicine and Telecare|June 7, 2019
Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural settingBenjamin Ruf, Phillip Jenkinson, David Armour, et al.
Trends in Immunology|June 15, 2024
Innate-like T cells in liver diseaseAlbert Ying-Po Yang, Kilian Wistuba-Hamprecht, Tim F Greten, et al.
Journal of Gastrointestinal Cancer|May 2, 2022
Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic SurveillanceBenjamin Ruf, Cristiana Roggia, Christopher Schroeder, et al.
Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Molecular Therapy Oncolytics|April 28, 2016
Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinomaBenjamin Ruf, Susanne Berchtold, Sascha Venturelli, et al.
Cancers|May 13, 2023
Anti-Cancer Activity of Verteporfin in CholangiocarcinomaJihye L Golino, Xin Wang, Jing Bian, et al.
Pageof 4